Brookdale Senior Living (BKD)
(Delayed Data from NYSE)
$6.62 USD
+0.02 (0.30%)
Updated Oct 2, 2024 04:00 PM ET
After-Market: $6.62 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
C Value A Growth B Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$6.62 USD
+0.02 (0.30%)
Updated Oct 2, 2024 04:00 PM ET
After-Market: $6.62 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
C Value A Growth B Momentum A VGM
Zacks News
Why Brookdale May Not Be a Safe Bet Despite 34-Month Occupancy Growth
by Zacks Equity Research
Rising operating costs due to inflationary challenges in the senior living industry and higher estimated insurance expenses are likely to keep BKD's margins under pressure.
Brookdale (BKD) Down 7% Since Q2 Earnings Miss on Lower Interest
by Zacks Equity Research
Brookdale (BKD) expects adjusted EBITDA for the third quarter in the range of $90-$95 million.
Brookdale Senior (BKD) Q2 Occupancy Jumps, Growth Trend Persists
by Zacks Equity Research
Brookdale Senior's (BKD) weighted average occupancy for June rises 140 bps year over year.
Brookdale (BKD) Shows Fast-paced Momentum But Is Still a Bargain Stock
by Zacks Equity Research
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Brookdale (BKD) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.
Brookdale Senior Living (BKD) Is Up 6.55% in One Week: What You Should Know
by Zacks Equity Research
Does Brookdale Senior Living (BKD) have what it takes to be a top stock pick for momentum investors? Let's find out.
Elevance Health (ELV) Rallies 11.8% YTD: More Room to Run?
by Zacks Equity Research
Elevance Health's (ELV) performance benefits from new contract wins, a strong Carelon segment and recovering Medicaid business.
Brookdale (BKD) Sees 31 Months of Y/Y Occupancy Growth Streak
by Zacks Equity Research
Brookdale's (BKD) weighted average occupancy for the second quarter-to-date rises 160 bps year over year to 78%.
Is Bicycle Therapeutics (BCYC) Stock Outpacing Its Medical Peers This Year?
by Zacks Equity Research
Here is how Bicycle Therapeutics PLC Sponsored ADR (BCYC) and Brookdale Senior Living (BKD) have performed compared to their sector so far this year.
Select Medical (SEM) Rises 42.4% YTD: More Growth Ahead?
by Zacks Equity Research
Select Medical (SEM) will continue to gain from rising admissions within the Critical Illness Recovery Hospital and Rehabilitation Hospital segments.
Will UnitedHealth (UNH) Dividend Hike Fail to Excite Investors?
by Zacks Equity Research
UnitedHealth's (UNH) strong financial position supports its shareholder value boosting efforts.
Cigna's (CI) Express Scripts Collaborates With CPESN USA
by Zacks Equity Research
Cigna's (CI) Express Scripts collaborates with CPESN USA in a bid to enhance care delivery for hypertension and diabetes patients.
Encompass Health (EHC) JV Opens Atlanta Rehabilitation Hospital
by Zacks Equity Research
The new facility in Georgia marks the 162nd inpatient rehabilitation hospital of Encompass Health (EHC) in the country.
Encompass Health (EHC) Opens Rehabilitation Hospital in Ballwin
by Zacks Equity Research
The 40-bed inpatient rehabilitation hospital is a JV between Encompass Health (EHC) and BJC HealthCare.
Elevance (ELV) Rises 14.9% YTD: What Lies Ahead for Investors?
by Zacks Equity Research
Elevance (ELV) continues to focus on increasing shareholder value with consistent dividend payouts and stock repurchases.
Brookdale (BKD) Down 3% Post Q1 Earnings: What Lies Ahead?
by Zacks Equity Research
Elevated facility operating costs and lower interest income strain Brookdale's (BKD) Q1 results, which were partly offset by favorable occupancy rates fetching improved resident fees.
Are You Looking for a Top Momentum Pick? Why Brookdale Senior Living (BKD) is a Great Choice
by Zacks Equity Research
Does Brookdale Senior Living (BKD) have what it takes to be a top stock pick for momentum investors? Let's find out.
Acadia (ACHC), Geisinger JV Begin Construction of New Hospital
by Zacks Equity Research
The new hospital from Acadia (ACHC) and Geisinger JV is scheduled to open in spring 2025.
Here Is Why Bargain Hunters Would Love Fast-paced Mover Brookdale (BKD)
by Zacks Equity Research
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Brookdale (BKD) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.
Brookdale Senior (BKD) Sees Y/Y Increase in Q1 Occupancy Levels
by Zacks Equity Research
Brookdale Senior (BKD) witnesses 29 straight months of year-over-year increases in weighted average occupancy level.
Brookdale (BKD) February 2024 Weighted Average Occupancy Rises
by Zacks Equity Research
Brookdale (BKD) witnesses a continuous streak of 28 months of year-over-year improvements in the weighted average occupancy level.
Brookdale Senior's (BKD) Q4 Loss Widens, Shares Drop 13%
by Zacks Equity Research
Brookdale Senior's (BKD) Q4 results were hit by inflationary challenges, an increase in facility operating lease expense and higher income tax provision. It expects adjusted EBITDA within $90-$95 million in first-quarter 2024.
Tenet Healthcare (THC) Q4 Earnings Beat on Hospital Operations
by Zacks Equity Research
Tenet Healthcare (THC) expects net operating revenues to be between $19.9 billion and $20.3 billion in 2024.
Cigna (CI) Q4 Earnings Beat on Membership Growth, Dividend Up
by Zacks Equity Research
Cigna (CI) expects adjusted revenues to register a minimum growth of 20.3% from the 2023 reported figure.
Humana (HUM) Q4 Earnings Miss on Higher Costs, '25 Target Pulled
by Zacks Equity Research
Humana (HUM) expects 2024 revenues to increase to around $113 billion.
Elevance (ELV) Q4 Earnings Beat on Premium Growth, Dividend Hiked
by Zacks Equity Research
Elevance Health (ELV) expects 2024 premium revenues to remain in line with the 2023 level.